WASHINGTON (dpa-AFX) - The U.S. Food and Drug Administration, in coordination with the U.S. Department of Justice, has announced that the U.S. Marshals Service seized approximately 73,000 units of 7-hydroxymitragynine (7-OH) products valued at $1 million from three firms in Missouri.
FDA said the seizure focused on foods and dietary supplement products - including liquid shots and tablets - containing concentrated 7-OH as an added ingredient. Concentrated 7-OH is increasingly recognized as having potential for abuse because of its ability to bind to opioid receptors. It cannot be lawfully added to dietary supplements or conventional foods. These products are considered adulterated because 7-OH does not meet applicable safety standards. Also, the FDA has not approved 7-OH for medical use.
'This enforcement action is a strong step to protect Americans from the dangers of concentrated 7-OH products, which are potent opioids,' said FDA Commissioner Marty Makary. 'We must be proactive and vigilant to address emerging threats to our communities and our kids.'
The FDA worked closely with the Missouri Department of Health and Senior Services in this enforcement action, which builds on the FDA's comprehensive efforts to protect Americans from dangerous, illegal opioid substances. In July, the FDA recommended the scheduling of certain 7-OH products under the Controlled Substances Act and issued warning letters to companies for illegally distributing products containing 7-OH, including tablets, gummies, drink mixes and shots. FDA also notified health care professionals and informed consumers of the risks associated with concentrated 7-OH products.
Copyright(c) 2025 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
© 2025 AFX News